Business context and reporting period
OneMedNet Corporation filed this Form 8-K regarding a corporate-action event dated September 26, 2026. The filing reports a 1-for-10 reverse stock split, approved by stockholders on September 18 and scheduled to take effect at 12:01 a.m. Eastern Time on September 29, 2026. The filing does not report operating results for a financial reporting period.
Key financial and capital facts
- Approximately 60,125,902 common shares outstanding as of September 27, 2026, expected to become approximately 6,012,591 shares after the split.
- No fractional shares will be issued; fractional amounts will be rounded up to the nearest whole share.
- The split does not change the authorized share count, common-stock par value, or voting rights.
- Outstanding equity awards, warrants, convertible securities, and equity-plan share reserves will be proportionately adjusted under their terms. The filing does not specify revised instrument counts or exercise prices.
- The filing provides no revenue, profit, cash flow, margin, debt, or liquidity figures.
Material change and rationale
The company said the reverse split is intended to help meet Nasdaq Capital Market minimum bid-price requirements. Following the split, the common stock will continue trading on Nasdaq under ticker ONMD; the new CUSIP is 68270C 202.
Outlook, risks, and unusual items
No financial guidance or operating outlook is provided. The filing describes the split as a listing-compliance measure; it does not state that compliance has been achieved or provide the company’s subsequent bid-price status.
Investor facts to verify
- Confirm the reverse split became effective on September 29, 2026, and the post-split share count.
- Check Nasdaq’s continued-listing status and whether the minimum bid-price requirement was satisfied.
- Review the filed certificate of amendment and relevant security terms for adjustments to warrants, awards, and convertible securities.